Intuitive Ventures Closes $150 Million Fund II
With $250 million in assets under management, the corporate venture firm’s global focus spans diagnostics, MedTech, therapies, and digital health
Read MoreWith $250 million in assets under management, the corporate venture firm’s global focus spans diagnostics, MedTech, therapies, and digital health
Read Moreto Make the Unseen Seen in Orthopedic, Neuro, and Spine Surgery
Read Moreto achieve FDA 510(k) clearance of the Glean™ Urodynamics System
Read MoreGilde Healthcare invests in companies in Europe and North America active in digital healthcare, medical technology (MedTech) and therapeutics, and the new fund will invest €10-70 million per new portfolio company
Read MoreFunding will allow the company to bring novel technology that illuminates lung and ovarian cancer during surgery to more patients
Read Moreto bring FDA-Cleared IntelliSep® Test to Hospitals Nationwide to Support Early Detection and Treatment of Serious Condition
Read MoreInvestment will drive commercialization and expansion of AI-powered non-invasive diagnostic tools to help evaluate cardiovascular risk
Read Moreto Accelerate Development and Expansion of AR Augmented Reality Surgical Navigation System – Caduceus S
Read Morewhich will support the company’s clinical validation and regulatory submissions to enable commercialization
Read MoreThe company focuses on the field of flow diagnostics, covering raw materials to product development and clinical application research, and provides innovative total solutions.
Read More